These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7774053)

  • 41. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.
    Ngure P; Ng'ang'a Z; Kimutai A; Kepha S; Mong'are S; Ingonga J; Tonui W
    Pan Afr Med J; 2014; 17 Suppl 1(Suppl 1):15. PubMed ID: 24624248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
    Velasquez LG; Galuppo MK; DE Rezende E; Brandão WN; Peron JP; Uliana SR; Duarte MI; Stolf BS
    Parasitology; 2016 May; 143(6):692-703. PubMed ID: 26892342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism.
    Hoerauf A; Röllinghoff M; Solbach W
    Int Immunol; 1996 Oct; 8(10):1569-75. PubMed ID: 8921436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Requirement of SIRPα for protective immunity against Leishmania major.
    Morimoto N; Murata Y; Motegi S; Suzue K; Saito Y; Okazawa H; Ohnishi H; Kotani T; Kusakari S; Ishikawa O; Matozaki T
    Biochem Biophys Res Commun; 2010 Oct; 401(3):385-9. PubMed ID: 20854790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With
    Kauffmann F; Meert E; de Jonge K; Elkrim Y; Hanot Mambres D; Denis O; Muraille E; Magez S; De Trez C
    Front Immunol; 2018; 9():503. PubMed ID: 29593739
    [No Abstract]   [Full Text] [Related]  

  • 48. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L; Troutt AB; Handman E; Kelso A
    J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant interleukin 12 cures mice infected with Leishmania major.
    Heinzel FP; Schoenhaut DS; Rerko RM; Rosser LE; Gately MK
    J Exp Med; 1993 May; 177(5):1505-9. PubMed ID: 8097524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease.
    Hoerauf A; Solbach W; Röllinghoff M; Gessner A
    Int Immunol; 1995 Nov; 7(11):1879-84. PubMed ID: 8580086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection.
    Ota H; Takashima Y; Matsumoto Y; Hayashi Y; Matsumoto Y
    J Vet Med Sci; 2008 Jun; 70(6):589-93. PubMed ID: 18628599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection.
    Rodriguez-Sosa M; Rosas LE; Terrazas LI; Lu B; Gerard C; Satoskar AR
    Immunol Cell Biol; 2003 Apr; 81(2):114-20. PubMed ID: 12631234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leishmania major: recruitment of Gr-1+ cells into draining lymph nodes during infection is important for early IL-12 and IFN gamma production.
    dos Santos MS; Vaz Cardoso LP; Nascimento GR; Lino Rde S; Dorta ML; de Oliveira MA; Ribeiro-Dias F
    Exp Parasitol; 2008 Jul; 119(3):403-10. PubMed ID: 18501355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype.
    Müller I; Freudenberg M; Kropf P; Kiderlen AF; Galanos C
    Med Microbiol Immunol; 1997 Oct; 186(2-3):75-81. PubMed ID: 9403834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF.
    Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA
    Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis.
    Satoskar A; Brombacher F; Dai WJ; McInnes I; Liew FY; Alexander J; Walker W
    J Immunol; 1997 Nov; 159(10):5005-13. PubMed ID: 9366428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.